↓ Skip to main content

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update

Overview of attention for article published in Clinical Pharmacology & Therapeutics, April 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news
2 news outlets
twitter
1 X user

Citations

dimensions_citation
483 Dimensions

Readers on

mendeley
445 Mendeley
Title
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update
Published in
Clinical Pharmacology & Therapeutics, April 2017
DOI 10.1002/cpt.668
Pubmed ID
Authors

JA Johnson, KE Caudle, L Gong, M Whirl‐Carrillo, CM Stein, Scott, MT Lee, BF Gage, Kimmel, MA Perera, JL Anderson, M Pirmohamed, TE Klein, NA Limdi, LH Cavallari, M Wadelius

Abstract

This document is an update to the 2011 Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2C9 and VKORC1 genotypes and warfarin dosing. Evidence from the published literature is presented for CYP2C9, VKORC1, CYP4F2, and rs12777823 genotype-guided warfarin dosing to achieve a target international normalized ratio of 2-3 when clinical genotype results are available. In addition, this updated guideline incorporates recommendations for adult and pediatric patients that are specific to continental ancestry. This article is protected by copyright. All rights reserved.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 445 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Unknown 444 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 65 15%
Student > Master 59 13%
Researcher 49 11%
Student > Ph. D. Student 41 9%
Student > Doctoral Student 23 5%
Other 73 16%
Unknown 135 30%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 80 18%
Pharmacology, Toxicology and Pharmaceutical Science 77 17%
Medicine and Dentistry 66 15%
Agricultural and Biological Sciences 23 5%
Nursing and Health Professions 7 2%
Other 41 9%
Unknown 151 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 July 2022.
All research outputs
#1,938,098
of 24,477,448 outputs
Outputs from Clinical Pharmacology & Therapeutics
#299
of 4,370 outputs
Outputs of similar age
#37,246
of 313,327 outputs
Outputs of similar age from Clinical Pharmacology & Therapeutics
#7
of 33 outputs
Altmetric has tracked 24,477,448 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,370 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 313,327 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.